Farmed Trout Disease Welfare Management

Rainbow trout farming faces significant disease challenges including infectious pancreatic necrosis and bacterial kidney disease, with welfare implications from both disease and treatment methods requiring integrated health management approaches.

Key Facts

Rainbow trout are the most commonly farmed salmonid in Europe and North America after Atlantic salmon
Infectious pancreatic necrosis virus causes significant mortality and welfare impact in farmed trout
Bacterial kidney disease causes chronic welfare harm with internal lesions and reduced immune function
Vaccination has significantly reduced some disease impacts but cannot address all common trout pathogens
Water temperature management is critical as warmer water increases disease susceptibility and welfare risk

Welfare Considerations

Farmed trout disease creates significant welfare suffering through acute mortality events and chronic infection causing pain, reduced function, and impaired immune response. Disease prevention through vaccination, water quality management, and appropriate stocking density is more welfare-positive than relying on treatment of established disease. Antibiotic treatment addresses immediate welfare harm but raises antimicrobial resistance concerns. Integrated health management that combines vaccination, stocking density management, water temperature control, and genetic selection for disease resistance offers the most welfare-positive and sustainable approach to trout production.

What You Can Do

Choose farmed trout from producers with documented disease management and welfare monitoring programs
Support certification schemes that include disease management and treatment welfare standards for salmonids
Advocate for stocking density standards that reduce disease pressure in trout farming systems
Support research into disease-resistant trout breeding and vaccine development
Reduce farmed trout consumption while better-welfare production systems continue to develop